COPD

 

COPD: Pathological Essentials

COPD is a chronic, progressive airflow obstruction that is not fully reversible. It encompasses two primary, often overlapping, disease processes: Chronic Bronchitis and Emphysema.

1. Comparison: Chronic Bronchitis vs. Emphysema

Feature Chronic Bronchitis Emphysema
Pathology Mucus gland hypertrophy/hyperplasia. Destruction of alveolar walls.
Reid Index Increased (>0.4). Normal.
Clinical Phenotype Blue Bloater (cyanosis, edema). Pink Puffer (pursed lips, cachectic).

2. Emphysema Subtypes

  • Centriacinar: Most common; affects the respiratory bronchioles. Strongly associated with smoking; predominant in the upper lobes.
  • Panacinar: Affects both alveoli and respiratory bronchioles. Associated with Alpha-1 Antitrypsin (AAT) deficiency; predominant in the lower lobes.

3. Exam Must-Knows

  • AAT Deficiency: Classic cause of early-onset emphysema in a non-smoker. Liver involvement is also common (PAS-positive globules in hepatocytes).
  • Mechanism of Damage: Protease-antiprotease imbalance (neutrophil elastase activity is unchecked).
  • Spirometry: Decreased FEV1/FVC ratio (<0.7) and increased Total Lung Capacity (TLC).

Pathology Pearl: Chronic bronchitis is defined clinically as a persistent productive cough for at least 3 months in at least 2 consecutive years.